Drugs / Aldehyde Dehydrogenase-Bright
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00314366 Comparator | Apr 2006 → Aug 2009 | coronary artery disorder | Texas Heart Institute | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aldehyde Dehydrogenase-Bright | “This is a phase I, double blind trial to evaluate the use of Aldehyde Dehydrogenase-Bright (ALDHbr) in ischemic cardiomyopathy patients.” NCT00314366 ↗ |
| Known as | ALDHbr | “This is a phase I, double blind trial to evaluate the use of Aldehyde Dehydrogenase-Bright (ALDHbr) in ischemic cardiomyopathy patients.” NCT00314366 ↗ |
| Modality | Cell therapy | “Aldehyde Dehydrogenase-Bright stem cells” NCT00314366 ↗ |
| Route | Other | “transendocardial injections of autologous bone marrow cells” NCT00314366 ↗ |